On-demand Webinar
Sponsored by Phillips Medisize
3:00 pm CET
As a contract design and manufacturing organization (CDMO), Phillip-Medisize works closely with our customers to deliver proven, highly engineered products that help millions of people live healthier, more productive lives. Autoinjectors and pens for delivering insulin, GLP1, epinephrine and other life-saving drug treatments. Advanced, wearable injection pumps. Point-of-care and at home diagnostic tests. Electrophysiology technology. Continuous glucose monitoring systems.
This webinar will provide an overview of drug delivery CDMO trends and technologies and address the importance of having a strong global footprint.
Qing Li
Head of Business Development
Phillips Medisize
Mr. Li Qing, Head of Business Development for China in Phillips - Medisize, with over 20 years of strong experiences in field of Drug Delivery solutions for Pharmaceutical Industry, having worked across Sales, Marketing and Technical Support functions in various multinational organizations SG, Gerresheimer Buende GmbH, Becton Dickinson.
Phillips-Medisize company structure
CDMO capabilities
Benefits of Design Capabilities in a CDMO
Platforms in Drug Delivery
Wayne Zou
+86 -21 3339 2546
wayne.zou@imsinoexpo.com
FEATURED
Product:
OUR